Visalytics
Visalytics
approved EB-2 (NIW)

Teaching Associate And Technical Sales Specialist

Microbiology · Nepal · 2025-04-05

Processing Time
485 days
Decision Date
2025-04-05
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop vaccines using advanced molecular biology and immunological approaches to target bacterial pathogens resistant to standard antibiotics. The work specifically focuses on Neisseria gonorrhoeae, a major antimicrobial resistance threat in the U.S., to create novel vaccine design strategies.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses antimicrobial resistance, which causes millions of infections and tens of thousands of deaths annually in the U.S.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to a Ph.D., a strong publication record in high-impact journals, and significant citation metrics.

3 Balance of Factors Met

The petitioner's contributions to vaccine platforms and infectious disease prevention make it beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in biochemistry and molecular biology, 9 peer-reviewed articles in high-impact journals like Nature Microbiology, and 362 citations. The case demonstrated national importance through alignment with urgent health priorities and was supported by a history of research funding from the NHMRC of Australia.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Ethiopia

WeGreened EB-2 (NIW) approved
Tennessee 64 days 2025-03-13
The petitioner proposes to advance innovative immunization strategies and translational studies aimed at developing effective vaccines and therapeutics targeting infectious pathogens. The work focuses on investigating host-pathogen interactions and the underlying mechanisms of protective immune responses to strengthen public health systems.
View Case

Doctor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
Florida 18 days 2025-03-01
The petitioner proposes to study the mechanisms and prevalence of antimicrobial resistance (AMR) and explore strategies to limit its spread. His work involves screening, vaccinating, and treating infections, monitoring antimicrobial susceptibilities, and conducting early detection of various medical conditions to address challenges in future pandemic-related health emergencies.
View Case

Research Assistant

Biotechnology · Egypt

WeGreened EB-2 (NIW) rfe approved
Massachusetts 395 days 2025-07-17
The petitioner proposes to continue research in microbiology focused on discovering antimicrobial agents and elucidating their mechanisms to combat multidrug-resistant bacteria. The work involves developing phage therapies, nanoparticle-drug hybrids, and innovative antimicrobial delivery systems to replace or augment conventional antibiotics. This endeavor aims to address the global healthcare emergency of antibiotic resistance and improve drug treatment efficacy.
View Case

Research Scientist

Pharmaceuticals · China

WeGreened EB-2 (NIW) approved
Utah 52 days 2025-03-07
The petitioner proposes to design and develop novel antimicrobial compounds for in vitro and in vivo applications to combat resistant pathogens and bridge the gap between basic discovery and clinical translation.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Nepal

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-05.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 485 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Nepal All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist